HK Stock MarketDetailed Quotes

BAMBOOSHEALTH (02293)

Watchlist
  • 0.380
  • 0.0000.00%
Market Closed May 18 16:47 CST
152.93MMarket Cap9.05P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BAMBOOSHEALTH (02293) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Dec 31, 2025
(FY)Jun 30, 2025
(Q6)Dec 31, 2024
(FY)Jun 30, 2024
(Q6)Dec 31, 2023
(FY)Jun 30, 2023
(Q6)Dec 31, 2022
(FY)Jun 30, 2022
(Q6)Dec 31, 2021
(FY)Jun 30, 2021
Turnover
-11.47%34.94M
-21.50%74.4M
-20.59%39.47M
-25.10%94.79M
-26.57%49.7M
-9.79%126.56M
-7.32%67.69M
27.93%140.3M
95.16%73.04M
51.65%109.67M
Operating income
-11.47%34.94M
-21.50%74.4M
-20.59%39.47M
-25.10%94.79M
-26.57%49.7M
-9.79%126.56M
-7.32%67.69M
27.93%140.3M
95.16%73.04M
51.65%109.67M
Operating expenses
Gross profit
Employee expense
-7.11%-15.35M
-6.23%-27.64M
-17.34%-14.33M
32.81%-26.02M
8.94%-12.21M
6.17%-38.72M
-6.42%-13.41M
-71.35%-41.27M
-7.60%-12.6M
-0.14%-24.08M
Depreciation and amortization
5.20%-4.54M
8.66%-9.26M
2.52%-4.79M
-1.43%-10.14M
13.89%-4.91M
-29.95%-9.99M
-131.08%-5.7M
-76.31%-7.69M
10.22%-2.47M
24.86%-4.36M
Special items of operating profit
40.62%-3.88M
25.36%-13.37M
43.13%-6.53M
0.48%-17.91M
-15.96%-11.49M
1.00%-18M
36.42%-9.91M
-141.13%-18.18M
-2,261.30%-15.58M
-19.23%-7.54M
Operating profit
-19.14%11.18M
-40.72%24.14M
-34.47%13.82M
-31.95%40.72M
-45.45%21.09M
-18.20%59.85M
-8.77%38.67M
-0.71%73.16M
78.95%42.38M
103.88%73.68M
Financing income
-50.87%397K
20.64%1.58M
-5.61%808K
68.98%1.31M
3,790.91%856K
1,366.04%777K
-64.52%22K
-40.45%53K
40.91%62K
-91.51%89K
Financing cost
44.57%-955K
-17.36%-3.29M
-85.07%-1.72M
-44.05%-2.81M
-66.55%-931K
-151.35%-1.95M
-240.85%-559K
-279.90%-775K
-37.82%-164K
37.42%-204K
Share of profit from joint venture company
----
----
----
----
----
----
----
----
----
87.03%-89K
Earning before tax
-17.73%10.62M
-42.83%22.43M
-38.59%12.91M
-33.14%39.23M
-44.88%21.02M
-19.00%58.67M
-9.82%38.13M
-1.42%72.44M
78.66%42.28M
103.12%73.48M
Tax
52.43%-1.33M
41.18%-4.89M
28.13%-2.8M
29.31%-8.31M
48.43%-3.89M
14.92%-11.76M
14.10%-7.55M
-10.91%-13.82M
-121.98%-8.79M
-127.09%-12.46M
After-tax profit from continuing operations
-8.12%9.29M
-43.27%17.54M
-40.97%10.11M
-34.10%30.92M
-44.01%17.12M
-19.96%46.92M
-8.69%30.58M
-3.94%58.62M
69.95%33.49M
98.83%61.02M
Earning after tax
-8.12%9.29M
-43.27%17.54M
-40.97%10.11M
-34.10%30.92M
-44.01%17.12M
-19.96%46.92M
-8.69%30.58M
-3.94%58.62M
69.95%33.49M
98.83%61.02M
Profit attributable to shareholders
-8.12%9.29M
-43.27%17.54M
-40.97%10.11M
-34.10%30.92M
-44.01%17.12M
-19.96%46.92M
-8.69%30.58M
-3.94%58.62M
69.95%33.49M
98.83%61.02M
Basic earnings per share
-7.97%0.0231
-43.34%0.0438
-41.36%0.0251
-34.10%0.0773
-44.05%0.0428
-19.99%0.1173
-8.60%0.0765
-3.93%0.1466
69.78%0.0837
98.96%0.1526
Diluted earnings per share
-7.97%0.0231
-43.47%0.0437
-41.36%0.0251
-34.10%0.0773
-44.05%0.0428
-19.99%0.1173
-8.60%0.0765
-3.93%0.1466
69.78%0.0837
98.96%0.1526
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
PwC
--
PwC
--
PwC
(Q6)Dec 31, 2025(FY)Jun 30, 2025(Q6)Dec 31, 2024(FY)Jun 30, 2024(Q6)Dec 31, 2023(FY)Jun 30, 2023(Q6)Dec 31, 2022(FY)Jun 30, 2022(Q6)Dec 31, 2021(FY)Jun 30, 2021
Turnover -11.47%34.94M-21.50%74.4M-20.59%39.47M-25.10%94.79M-26.57%49.7M-9.79%126.56M-7.32%67.69M27.93%140.3M95.16%73.04M51.65%109.67M
Operating income -11.47%34.94M-21.50%74.4M-20.59%39.47M-25.10%94.79M-26.57%49.7M-9.79%126.56M-7.32%67.69M27.93%140.3M95.16%73.04M51.65%109.67M
Operating expenses
Gross profit
Employee expense -7.11%-15.35M-6.23%-27.64M-17.34%-14.33M32.81%-26.02M8.94%-12.21M6.17%-38.72M-6.42%-13.41M-71.35%-41.27M-7.60%-12.6M-0.14%-24.08M
Depreciation and amortization 5.20%-4.54M8.66%-9.26M2.52%-4.79M-1.43%-10.14M13.89%-4.91M-29.95%-9.99M-131.08%-5.7M-76.31%-7.69M10.22%-2.47M24.86%-4.36M
Special items of operating profit 40.62%-3.88M25.36%-13.37M43.13%-6.53M0.48%-17.91M-15.96%-11.49M1.00%-18M36.42%-9.91M-141.13%-18.18M-2,261.30%-15.58M-19.23%-7.54M
Operating profit -19.14%11.18M-40.72%24.14M-34.47%13.82M-31.95%40.72M-45.45%21.09M-18.20%59.85M-8.77%38.67M-0.71%73.16M78.95%42.38M103.88%73.68M
Financing income -50.87%397K20.64%1.58M-5.61%808K68.98%1.31M3,790.91%856K1,366.04%777K-64.52%22K-40.45%53K40.91%62K-91.51%89K
Financing cost 44.57%-955K-17.36%-3.29M-85.07%-1.72M-44.05%-2.81M-66.55%-931K-151.35%-1.95M-240.85%-559K-279.90%-775K-37.82%-164K37.42%-204K
Share of profit from joint venture company ------------------------------------87.03%-89K
Earning before tax -17.73%10.62M-42.83%22.43M-38.59%12.91M-33.14%39.23M-44.88%21.02M-19.00%58.67M-9.82%38.13M-1.42%72.44M78.66%42.28M103.12%73.48M
Tax 52.43%-1.33M41.18%-4.89M28.13%-2.8M29.31%-8.31M48.43%-3.89M14.92%-11.76M14.10%-7.55M-10.91%-13.82M-121.98%-8.79M-127.09%-12.46M
After-tax profit from continuing operations -8.12%9.29M-43.27%17.54M-40.97%10.11M-34.10%30.92M-44.01%17.12M-19.96%46.92M-8.69%30.58M-3.94%58.62M69.95%33.49M98.83%61.02M
Earning after tax -8.12%9.29M-43.27%17.54M-40.97%10.11M-34.10%30.92M-44.01%17.12M-19.96%46.92M-8.69%30.58M-3.94%58.62M69.95%33.49M98.83%61.02M
Profit attributable to shareholders -8.12%9.29M-43.27%17.54M-40.97%10.11M-34.10%30.92M-44.01%17.12M-19.96%46.92M-8.69%30.58M-3.94%58.62M69.95%33.49M98.83%61.02M
Basic earnings per share -7.97%0.0231-43.34%0.0438-41.36%0.0251-34.10%0.0773-44.05%0.0428-19.99%0.1173-8.60%0.0765-3.93%0.146669.78%0.083798.96%0.1526
Diluted earnings per share -7.97%0.0231-43.47%0.0437-41.36%0.0251-34.10%0.0773-44.05%0.0428-19.99%0.1173-8.60%0.0765-3.93%0.146669.78%0.083798.96%0.1526
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--PwC--PwC--PwC

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.81%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.82%
4
SINOPEC CORP
00386
-1.54%
5
SHANGHAI PECHEM
00338
-2.36%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +36.67%
Sample Name
Sample Code
 +29.14%
Sample Name
Sample Code
 +25.72%
4
Digital China Group
000034
+19.11%
5
Business-intelligence Of Oriental Nations Corporation
300166
+17.75%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -